e-learning
resources
Courses
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of CTEPH and anticoagulation of choice
J. Barberà
Source:
ERS Course 2019 - Masterclass in pulmonary embolism
Number:
10
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Barberà. Treatment of CTEPH and anticoagulation of choice. ERS Course 2019 - Masterclass in pulmonary embolism
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Diagnosis and treatment of chronic pulmonary embolism
Related content which might interest you:
Comparision of side effects between thrombolytic and anticoagulation therapy in patients with Pulmonary Embolism
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures
Source: Eur Respir Rev, 26 (145) 170020; 10.1183/16000617.0020-2017
Year: 2017
Effectiveness of thrombolytic therapy in pulmonary thromboembolism
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007
Rivaroxaban versus standard anticoagulation for the treatment of pulmonary embolism: a real-life study
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
The use of new anticoagulants in CTEPH
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Management of recurrent PE in patients on anticoagulant therapy
Source: Virtual Congress 2021 – Pulmonary embolism: special situations
Year: 2021
Complications of anticoagulant therapy in patients with pulmonary thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 604s
Year: 2007
The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019
Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach
Source: Eur Respir J 2015; 45: 1142-1149
Year: 2015
Initial dual oral combination therapy in inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Comparison of two regimens of oral anticoagulation in pulmonary embolism
Source: Eur Respir J 2006; 28: Suppl. 50, 632s
Year: 2006
Thrombolytic therapy in massive pulmonary thromboembolism
Source: Eur Respir J 2002; 20: Suppl. 38, 237s
Year: 2002
Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease
Source: Annual Congress 2004 - Treatment of pulmonary hypertension
Year: 2004
Sequential multimodal therapy in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
Thrombolytic therapy in cases with massive pulmonary thromboembolism
Source: Eur Respir J 2005; 26: Suppl. 49, 521s
Year: 2005
Safety and efficacy of immunoadsorption as an add-on to medical treatment in patients with idiopathic pulmonary arterial hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 272s
Year: 2005
Successful pregnancy outcome in patients with pulmonary arterial hypertension receiving prostayclin therapy
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy
Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension
Year: 2019
Management of bleeding during anticoagulant therapy
Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept